Remove 2023 Remove Drug Development Remove Medical Technology Remove Pharmaceuticals
article thumbnail

Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to Acquire the Company’s Digital Pathology Business

Healthcare IT Today

Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development. “A Dynamyx technology ownership and ongoing development and engineering will be led in the U.S.